The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children

被引:59
作者
Chen, DX [1 ]
Barniak, V [1 ]
VanDerMeid, KR [1 ]
McMichael, JC [1 ]
机构
[1] Wyeth Lederle Vaccines, W Henrietta, NY 14586 USA
关键词
D O I
10.1128/IAI.67.3.1310-1316.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The UspA1 and UspA2 proteins from Moraxella catarrhalis share antigenic epitopes and are promising vaccine candidates, In this study, the levels and bactericidal activities of antibodies in sera from healthy adults and children toward UspA1 and UspA2 from the O35E strain were measured. Human sera contained antibodies to both proteins, and the levels of immunoglobulin Cr (IgG) antibodies were age dependent, Adult sera had significantly higher titers of IgG than child sera (P < 0.01), The IgG3 titers to the UspA proteins were higher than the IgG1 titers in the adults' sera, while the IgG1 titers were higher than the IgG3 titers in the children's sera (P < 0.05). The IgG antibodies in the sera from 2-month-old children appeared to be maternally derived, since the mean titer was significantly higher than that in sera from 6- to 7-month-old children (P < 0.05), Serum IgA antibodies to both UspA1 and UspA2 were low during the first 7 months of age but thereafter gradually increased along with the Ige titers, Analysis of sera absorbed with UspA1 or UspA2 showed that the antibodies to UspA1 and UspA2 were cross-reactive with each other and associated with serum bactericidal activity. Examination of affinity-purified human antibodies confirmed that naturally acquired antibodies to UspA1 and UspA2 were bactericidal and cross-reactive. These results support using UspA1 and UspA2 in a vaccine to prevent M. catarrhalis infections.
引用
收藏
页码:1310 / 1316
页数:7
相关论文
共 30 条
  • [1] Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E
    Aebi, C
    Lafontaine, ER
    Cope, LD
    Latimer, JL
    Lumbley, SL
    McCracken, GH
    Hansen, EJ
    [J]. INFECTION AND IMMUNITY, 1998, 66 (07) : 3113 - 3119
  • [2] Bamberger D M, 1991, Semin Respir Infect, V6, P77
  • [3] OTITIS-MEDIA AND SINUSITIS IN CHILDREN - ROLE OF BRANHAMELLA-CATARRHALIS
    BLUESTONE, CD
    [J]. DRUGS, 1986, 31 : 132 - 141
  • [4] 10-YEAR REVIEW OF OTITIS-MEDIA PATHOGENS
    BLUESTONE, CD
    STEPHENSON, JS
    MARTIN, LM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (08) : S7 - S11
  • [5] BRANHAMELLA (MORAXELLA) CATARRHALIS - PATHOGENIC SIGNIFICANCE IN RESPIRATORY-INFECTIONS
    BOYLE, FM
    GEORGHIOU, PR
    TILSE, MH
    MCCORMACK, JG
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (09) : 592 - 596
  • [6] CARSON RT, 1994, IMMUNOLOGY, V83, P107
  • [7] BRANHAMELLA-CATARRHALIS - AN ORGANISM GAINING RESPECT AS A PATHOGEN
    CATLIN, BW
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (04) : 293 - 320
  • [8] Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization
    Chen, DX
    McMichael, JC
    VanDerMeid, KR
    Hahn, D
    Mininni, T
    Cowell, J
    Eldridge, J
    [J]. INFECTION AND IMMUNITY, 1996, 64 (06) : 1900 - 1905
  • [9] SERUM ANTIBODY-RESPONSE TO PROTEINS OF MORAXELLA (BRANHAMELLA) CATARRHALIS IN PATIENTS WITH LOWER RESPIRATORY-TRACT INFECTION
    CHRISTENSEN, JJ
    RENNEBERG, J
    BRUUN, B
    FORSGREN, A
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (01) : 14 - 17
  • [10] RESPIRATORY-TRACT INFECTIONS DUE TO BRANHAMELLA-CATARRHALIS - EPIDEMIOLOGIC DATA FROM WESTERN-AUSTRALIA
    DIGIOVANNI, C
    RILEY, TV
    HOYNE, GF
    YEO, R
    COOKSEY, P
    [J]. EPIDEMIOLOGY AND INFECTION, 1987, 99 (02) : 445 - 453